Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
CELZ Stock | USD 2.43 0.02 0.82% |
Slightly above 53% of Creative Medical's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Creative Medical Technology suggests that some traders are interested. Creative Medical's investing sentiment can be driven by a variety of factors including economic data, Creative Medical's earnings reports, geopolitical events, and overall market trends.
Creative |
Creative Medical Technology Holdings, Inc. , a leader in the field of regenerative medicine with a focus on developing novel therapies i
Read at businesswire.com
Creative Medical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Creative Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Creative Medical Fundamental Analysis
We analyze Creative Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creative Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creative Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Creative Medical is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Creative Medical Tec Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Creative Medical stock to make a market-neutral strategy. Peer analysis of Creative Medical could also be used in its relative valuation, which is a method of valuing Creative Medical by comparing valuation metrics with similar companies.
Peers
Creative Medical Related Equities
CDIO | Cardio Diagnostics | 38.46 | ||||
UNCY | Unicycive Therapeutics | 9.59 | ||||
ZVSA | ZyVersa Therapeutics | 3.92 | ||||
ATXI | Avenue Therapeutics | 3.83 | ||||
ICU | LMF Acquisition | 3.69 | ||||
ADXN | Addex Therapeutics | 2.30 | ||||
REVB | Revelation Biosciences | 2.27 | ||||
SNGX | Soligenix | 0.86 | ||||
VRAX | Virax Biolabs | 1.63 | ||||
SONN | Sonnet Biotherapeutics | 5.71 | ||||
QNRX | Quoin Pharmaceuticals | 6.41 | ||||
PALI | Palisade Bio | 20.88 |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.